Our verdict
MEDVi advertises a compounded semaglutide injection at $99 initially and $199 for refills, while its branded-drug cards list medication separately from a membership fee. It is separate from MEDvidi, whose review covers a different visit-fee model. Confirm the selected medication, full charge and state availability before paying; the broad inclusion claims on MEDVi’s page need to be read alongside the product-specific charges.
Main trade-offs
- The $99 semaglutide injection promotion is first month only; refills are $199
- Branded medication prices are not published, on top of a $99 monthly membership
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
FDA warning letter on record — read the public record and the context below.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Readers who want to compare compounded semaglutide injection with branded GLP-1 care, and will verify the selected plan’s total first.
Consider other options if
Anyone who needs a published tablet refill price, a full branded medication price or a confirmed state list before intake.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Semaglutide injection $99 first month, $199 refills; tablet from $249 with refill unknown; branded cards $99 membership plus drug, despite conflicting headline
- Medications
- Semaglutide · Oral · Branded
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
Our review in detail
Full assessment
MEDVi’s rendered public GLP-1 page offers a compounded semaglutide injection at $99 for the first month and says refills are locked at $199. A dissolvable tablet starts at $249, but its ingredient and refill price are not stated. Branded Wegovy and Zepbound cards show a $99 membership plus the medication cost, even though the same page says “No membership or hidden fees” and elsewhere broadly says medication is included. Its terms limit service to certain states and leave final charges dependent on medication and pharmacy. The company names partner pharmacies, and the FDA sent it a February 2026 warning letter about labeling and “same active ingredient” claims. Confirm the selected drug, state access and total before paying.
What it is
An online weight-loss service run by MEDVi, LLC, a Delaware company based in Newark, Delaware. It is a separate company from MEDvidi, which has a similar name and runs a different visit-fee model. MEDVi sells compounded GLP-1 injections and dissolvable tablets, and arranges branded Wegovy injections, the Wegovy pill and Zepbound injections. Medical care is provided by clinicians of OpenLoop Health and the CareGLP Affiliated P.C.s; MEDVi itself does not prescribe or compound. It claims more than 500,000 patients and lists men's health, women's health, peptides and skincare lines, several of them marked as coming soon. It shows a LegitScript badge in its footer.
How care works
You complete an online evaluation, starting with your weight-loss goal and health history, then check out. An OpenLoop clinician reviews your answers after checkout and decides whether to prescribe; the answers you give can screen you out before that. If you are prescribed, the medication ships from a partner pharmacy to your door, with free expedited delivery. Follow-up runs through a patient portal with unlimited messaging and 24/7 support, and the site says dietitian visits and care coaching from medical assistants and registered dietitians are included, subject to insurance and copay eligibility. The Belle review describes a model with weekly check-ins from a registered dietitian included in the price. Three partner pharmacies are named with addresses: Triad Rx (Daphne, Alabama), RedRock Pharmacy (St. George, Utah) and Beaker Pharmacy & Compounding (McKinney, Texas). The terms of service say the service is available only in certain states and that you must contact customer service for the current list.
Costs, billing and cancellation
The rendered public page shows a promotional compounded semaglutide injection at $99 for the first month and says refills are locked at $199. This includes physician review, a personalized plan, guidance, a metabolic report, medication and shipping. A daily dissolvable tablet starts at $249; the page does not identify its molecule, dose or refill charge.
Branded Wegovy pill or injection and Zepbound injection cards say $99 membership plus medication, whose price is unpublished and may depend on coverage. The WellMedRx review shows why medication and membership charges should be confirmed separately before the first payment. The same page also says “No membership or hidden fees” and broadly says medication is included, so ask for an itemized branded quote. MEDVi’s terms say final charges can vary by drug and pharmacy. The selected state and pharmacy also matter.
Subscriptions renew automatically. Cancel at least 72 hours before the next billing date. A first-72-hour cancellation can be refunded if no services were received; medical disqualification is another exception. Monthly periods are otherwise not refunded, and prepaid unused months may be refundable if no medication shipped.
Medication and evidence
Compounded semaglutide by weekly injection, a compounded once-daily dissolvable tablet, and the branded, FDA-approved Wegovy injection, Wegovy pill and Zepbound. The injection's FAQ calls it the MEDVi semaglutide program; the tablet's active ingredient is not named on the public page, so ask. The disclaimer states that compounded GLP-1s are not FDA-approved or evaluated for safety, efficacy or quality. The trial evidence belongs to the branded drugs, and a dissolvable GLP-1 tablet has no published human absorption data. The site's figures of 18% average weight loss and 93% keeping it off come from MEDVi patients' self-reported weights, not a trial. In February 2026 the FDA issued warning letter 721455 to MEDVi, LLC. It objected to the MEDVi name on pictured vials, which suggested MEDVi compounds the drugs, and to the claims "same active ingredient as Wegovy® and Ozempic®" and "same active ingredient as Mounjaro® and Zepbound®", which the agency said imply FDA approval.
FDA warning letter on record
The FDA issued a warning letter naming MEDVi, LLC dba MEDVi, the company behind MEDVi.
- Letter 721455, issued February 20, 2026 — read it on fda.gov
We publish this because it is a matter of public record and a reader weighing this provider should have it. A warning letter is the FDA setting out alleged violations; it is not a court finding, and a company may have responded or corrected since. It does not remove MEDVi from this site, and it does not change our verdict — read the letter and decide for yourself.
Pros and watch-outs
What we like
- Compounded injections, compounded tablets and branded Wegovy, Wegovy pill and Zepbound in one account
- The semaglutide injection refill is stated as locked at $199
- Three partner pharmacies named with addresses, and the clinician networks identified
- Free expedited shipping, unlimited messaging and included dietitian support
- Company name and street address published
Watch-outs
- The $99 semaglutide injection promotion is first month only; refills are $199
- Branded medication prices are not published, on top of a $99 monthly membership
- FDA warning letter 721455 (February 2026) over its labels and "same active ingredient" claims
- Refund exceptions narrow after 72 hours, and the state list is available only on request
- Weight-loss and maintenance statistics are based on patient self-reports
Best for
Readers who want to compare compounded semaglutide injection with branded GLP-1 care, and will verify the selected plan’s total first.
Who should look elsewhere
Anyone who needs a published tablet refill price, a full branded medication price or a confirmed state list before intake.
Research relevant to MEDVi
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- GLP-1 pill vs injection: what you trade for swallowing it
Oral semaglutide 50 mg matched the injection to within 0.2 of a percentage point, but not at the approved dose, and the daily fasting protocol is the cost nobody mentions.
- The Wegovy pill (oral semaglutide 25 mg): what OASIS 4 actually showed
The first oral GLP-1 approved for weight loss — and why the −16.6% everyone quotes is not the trial's primary result.
- Compounded vs branded GLP-1: regulatory status, sourcing and the evidence
Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.
How MEDVi compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our Found review and Gala Health review describe what each service publishes about pricing, billing and cancellation.
FoundMultiple medication pathways and insurance for clinical visits
See Found →
Gala HealthA guided, program-style GLP-1 weight-care experience
See Gala Health →
OrderlyMedsBuyers who want one flat month-to-month price at every dose and a named pharmacy list
See OrderlyMeds →
More GLP-1 telehealth reviews: Avono HealthPanterra HealthFormBlendsThe Virtual NPSouthern Vitality and Weight LossMD Live
Access & cost
How we assessed this. This review is based on MEDVi’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does MEDVi cost after the first month?
- The rendered semaglutide injection offer is $99 for the first month and $199 for refills. A dissolvable tablet starts at $249; its ingredient and refill cost are unpublished. Branded cards show a $99 membership plus the drug, despite a conflicting no-membership headline.
- Is MEDVi the same company as MEDvidi?
- No. MEDVi is run by MEDVi, LLC of Newark, Delaware, and sells GLP-1 programs with the medication included. MEDvidi is a separate telehealth company with a different model and pricing. Check which one you are signing up with before you pay.
- Has MEDVi received an FDA warning letter?
- Yes. The FDA issued warning letter 721455 to MEDVi, LLC on February 20, 2026. It said the MEDVi name on pictured vials implied MEDVi compounds the drugs, and that claiming the products had the "same active ingredient" as Wegovy, Ozempic, Mounjaro and Zepbound implied FDA approval. The letter concerns marketing claims rather than a test of the medication.
- Can I get a refund from MEDVi?
- Only in narrow cases: if you cancel within the first 72 hours and have received no services, or if a provider disqualifies you for a medical reason. Monthly charges are otherwise not refunded. On plans billed two or more months at a time, you are refunded for months in which no medication was shipped.
- Which states does MEDVi serve?
- Its terms say the service is available in certain states only and that the current list is available from customer service. Ask before you complete the evaluation.
- Is MEDVi legit?
- FDA has a warning letter on record against MEDVi, LLC dba MEDVi, the company behind MEDVi, issued February 20, 2026 as letter 721455; it is linked further down this page. A warning letter is a public record worth reading. It doesn't by itself mean you can't use this provider. MEDVi is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Semaglutide, an oral form and branded medication. What it publishes up front: Semaglutide injection $99 first month, $199 refills; tablet from $249 with refill unknown; branded cards $99 membership plus drug, despite conflicting headline. It is cash-pay and states it does not bill insurance. Before you pay, ask in writing about which states it serves and your selected charge, billing interval, supply and required fees.
